Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > Financing extension
View:
Post by GrahamB on May 16, 2024 2:28am

Financing extension

Not here much at all, but will come back with material news.

If the net cash used in operating activities annually,is 3,803,894 according to the most recent audited annual financials on SEDAR and the cash on hand is  1,294,346 , and according to the recent PR: “the insider led first tranche of its previously announced non-brokered private placement of unsecured convertible debentures (“Debentures”) for gross proceeds of $941,000.”
 
 So rounding up, given total cash reserves of approximately 2.3 million,(as of year end and adding forward)  the cash on hand would be running thin by the end of the summer. 

 

Will be interested to see what happens with the financing, given that the initial portion was only met by insiders, and they just extended it. 
 At some point, the company needs to generate its own revenue, instead of relying on financing.
If there was ever a time for Sales, now is it.
Like I said, I follow the numbers, so that’s why I’m interested now. Good luck to those who follow the story, and I do hope that some sales start to materialize, and that those sales actually get approved, and the money finds its way to the companyvault. 

'All IMO
For education (mine) and entertainment only.
Dont invest based on what you read here.

Comment by jopatclo on May 16, 2024 6:49am
GranhamBWalk speculator FUD from Ventripoint for 2024 see his negative speculation verbal diare message. Now Ventripoint has worldwide sales. Good comment see 100% ok for me. @hassy @jgb1993 Here are some of the stats presented in the past (can be found at community wiki page). in US alone, GE has 40,000 cardiac ultrasound machines. assuming 10% of those are used for pediatric, we have 4 ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities